PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 12, 2013Blood326 citationsOpen Access

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

HGHeinz GisslingerMedical University of ViennaMGMirjana GotićUniversity of BelgradeJHJerzy HołowieckiThe Maria Sklodowska-Curie National Research Institute of Oncology

Key Points

Key points are not available for this paper at this time.

Abstract

Key Points Noninferiority of anagrelide in comparison with hydroxyurea in WHO-essential thrombocythemia, a phase 3 trial

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gisslinger et al. (2013) studied this question.

synapsesocial.com/papers/6a1fdfc4dfff2a7ea2430b4ehttps://doi.org/10.1182/blood-2012-07-443770
Ask AI
Helpful
Bookmark
Share
View Full Paper